Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer epidemiology"
DOI: 10.1016/j.canep.2019.101579
Abstract: BACKGROUND Preclinical studies suggest that β-blockers could exhibit anticancer properties in ovarian cancer. Similar effects have also been reported in observational studies, but their results remain inconsistent and could be impaired by methodological limitations. This…
read more here.
Keywords:
diagnosis;
blocker use;
ovarian cancer;
cancer ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2020 at "Bioscience Reports"
DOI: 10.1042/bsr20200721
Abstract: Abstract Background: Evidence remains inconsistent regarding the potential influence of β-blocker (BB) use on clinical outcomes in women with breast cancer. We aimed to evaluate the association between BB and prognosis of breast cancer in…
read more here.
Keywords:
women breast;
cancer;
breast cancer;
blocker use ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
1
Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2101902
Abstract: Abstract Background Recent observational studies linked β-adrenergic receptor blocker use with improved survival in patients with several cancer types, but there is no information on the potential effects of β-blockers in patients with bladder cancer.…
read more here.
Keywords:
bladder cancer;
blocker use;
cancer;
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Clinical and Experimental Hypertension"
DOI: 10.1080/10641963.2022.2055763
Abstract: ABSTRACT Purpose Pharmacological (angiotensin II receptor type 1 receptor blocker use) and non-pharmacological treatment (physical aerobic exercise) are important strategies to reduces blood pressure and control arterial hypertension; however, only few clinical studies have evaluated…
read more here.
Keywords:
training;
blocker use;
receptor blocker;
physical aerobic ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0274399
Abstract: Objective To analyze the diagnostic value of conducting urodynamic study (UDS) and show predictors for alpha blocker use 12 months after transurethral prostatectomy. Materials and methods Our study includes 406 participants that had a transurethral…
read more here.
Keywords:
surgery;
blocker use;
transurethral prostatectomy;
blocker ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.779462
Abstract: Background Prior studies provided inconsistent results regarding long-term effect of β-blocker use on clinical outcomes in postmyocardial infarction (MI) patients. Methods We searched for articles regarding long-term effect of β-blocker use on clinical outcomes in…
read more here.
Keywords:
term effect;
long term;
risk;
blocker use ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicina"
DOI: 10.3390/medicina58020320
Abstract: Background and Objectives: Drug-related bradyarrhythmia is a well-documented major adverse event among beta-blocker users and a potential cause for hospitalization or additional interventions. Whether beta-blocker use is associated with specific bradyarrhythmia presentations, and how this…
read more here.
Keywords:
beta blocker;
blocker use;
sinus;
blocker ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicina"
DOI: 10.3390/medicina58091177
Abstract: Background and objectives: The effect of beta-blocker use after discharge on patients with acute myocardial infarction (AMI) in the contemporary reperfusion era remains ambiguous. By applying meta-analysis, we sought to assess the role of beta-blockers…
read more here.
Keywords:
beta blocker;
beta;
blocker use;
use discharge ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicina"
DOI: 10.3390/medicina59010129
Abstract: Background and Objectives: Osteoporosis results in increasing morbidity and mortality in hemodialysis patients. The medication for treatment has been limited. There is evidence that beta-blockers could increase bone mineral density (BMD) and reduce the risk…
read more here.
Keywords:
hemodialysis patients;
beta blocker;
blocker use;
blocker ... See more keywords